Lupus nephritis and kidney transplantation: A narrative review of patient and graft outcomes. (PubMed, World J Nephrol) - Jul 4, 2026 - "Advances in immunosuppressive therapies, including newly approved agents such as voclosporin and belimumab, have further enhanced LN management. In addition, novel biomarkers such as urinary monocyte chemoattractant protein-1, B-cell activating factor and matrix metalloproteinase-7 show promise for monitoring disease activity and predicting post-transplant recurrence risk. A comprehensive appraisal of guidelines and contemporary studies is essential to refine management strategies and optimize long-term outcomes for patients with LN undergoing KT."
Journal • Review • Chronic Kidney Disease • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Systemic Lupus Erythematosus • Transplantation • CCL2 • MMP7
|
|
Muhammed Mubarak; Saima Ahmed; Tabassum Elahi
|